Published in Diabetes Care on May 01, 2004
Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) | NCT00005260
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90
Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension (2008) 1.77
Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.74
Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab (2011) 1.71
Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract (2013) 1.71
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract (2008) 1.69
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? Nat Rev Clin Oncol (2016) 1.66
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care (2011) 1.60
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Effects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study). Asian J Androl (2015) 1.39
Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity. J Clin Endocrinol Metab (2011) 1.33
Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol (2009) 1.30
Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes (2009) 1.28
Sex, diabetes and the kidney. Am J Physiol Renal Physiol (2009) 1.26
Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest (2007) 1.26
Prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Intern Med (2005) 1.25
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J Acquir Immune Defic Syndr (2011) 1.17
Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab (2009) 1.16
Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc (2006) 1.13
Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care (2010) 1.12
The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2. J Obes (2010) 1.11
Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab (2013) 1.11
Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk. Hum Hered (2010) 1.10
A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol (2012) 1.09
Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci (2010) 1.09
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol (2008) 1.08
Urological aspects of the metabolic syndrome. Nat Rev Urol (2011) 1.06
Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab (2008) 1.04
Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf) (2009) 1.02
Long-term effects of calorie restriction on serum sex-hormone concentrations in men. Aging Cell (2010) 1.02
Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab (2011) 1.02
Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01
Negative association between testosterone concentration and inflammatory markers in young men: a nested cross-sectional study. PLoS One (2013) 1.01
Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism (2008) 1.00
Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab (2011) 0.99
Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care (2011) 0.99
Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab (2009) 0.99
Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98
Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. Diabetes Care (2009) 0.96
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab (2009) 0.95
Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res (2009) 0.94
Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord (2011) 0.94
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol (2013) 0.93
Estradiol and metabolic syndrome in older italian men: The InCHIANTI Study. J Androl (2008) 0.90
48XXYY Syndrome in an Adult with Type 2 Diabetes Mellitus, Unilateral Renal Aplasia, and Pigmentary Retinitis. Case Rep Med (2010) 0.90
Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS One (2014) 0.90
Testosterone and vascular function in aging. Front Physiol (2012) 0.89
Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc (2013) 0.89
Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med Res Methodol (2016) 0.88
Expression of aromatase, androgen and estrogen receptors in peripheral target tissues in diabetes. Steroids (2010) 0.88
Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence. J Diabetes Investig (2014) 0.88
Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications. Asian J Androl (2012) 0.87
Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab (2010) 0.87
Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One (2013) 0.87
Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and metabolic syndrome. PLoS One (2013) 0.87
Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. J Family Community Med (2013) 0.87
Sex steroids and glucose metabolism. Asian J Androl (2014) 0.87
The role of hypogonadism in Klinefelter syndrome. Asian J Androl (2014) 0.86
Treadmill exercise inhibits apoptotic neuronal cell death with suppressed vascular endothelial growth factor expression in the retinas of the diabetic rats. J Exerc Rehabil (2013) 0.86
Endogenous sex hormones, metabolic syndrome, and diabetes in men and women. Curr Cardiol Rep (2014) 0.85
Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial. Med Sci Sports Exerc (2008) 0.85
Testosterone and metabolic syndrome. Asian J Androl (2015) 0.85
Testosterone-induced effects on lipids and inflammation. Mediators Inflamm (2013) 0.85
Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling. Circulation (2013) 0.84
Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome. Acta Paediatr (2011) 0.84
The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer. Adv Urol (2012) 0.84
Testosterone and metabolic syndrome: The link. Indian J Endocrinol Metab (2012) 0.84
Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy. Steroids (2010) 0.83
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment. Nutrients (2014) 0.83
Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging (2012) 0.83
Association of Body Mass Index with Depression, Anxiety and Suicide-An Instrumental Variable Analysis of the HUNT Study. PLoS One (2015) 0.83
Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks. Asian J Androl (2011) 0.82
Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden. Endocr Connect (2012) 0.82
The validity of androgen assays. Aging Male (2007) 0.81
Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome. Diabetes (2014) 0.81
Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med (2014) 0.81
Connecting the Lines between Hypogonadism and Atherosclerosis. Int J Endocrinol (2012) 0.81
Gender-specific effect of metabolic syndrome on rate adjusted QT interval in middle-aged participants of an atherosclerosis prevention program. Wien Klin Wochenschr (2007) 0.81
Protective effects of metformin on reproductive function in obese male rats induced by high-fat diet. J Assist Reprod Genet (2015) 0.80
The Relationship between Testosterone Deficiency and Men's Health. World J Mens Health (2013) 0.80
Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab (2014) 0.80
Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. J Spinal Cord Med (2016) 0.80
Testosterone Supplementation Improves Carbohydrate and Lipid Metabolism in Some Older Men with Abdominal Obesity. J Gerontol Geriatr Res (2014) 0.79
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy. J Clin Oncol (2016) 0.79
Endocrine causes of nonalcoholic fatty liver disease. World J Gastroenterol (2015) 0.79
Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes. J Diabetes Res (2016) 0.78
Testosterone regulates bone response to inflammation. Horm Metab Res (2014) 0.78
The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study. Clin Endocrinol (Oxf) (2013) 0.78
Resistance training increases SHBG in overweight/obese, young men. Metabolism (2013) 0.78
Circulating estrone levels are associated prospectively with diabetes risk in men of the Framingham Heart Study. Diabetes Care (2013) 0.78
Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study. Vasc Health Risk Manag (2016) 0.77
Testosterone treatment of older men--why are controversies created? J Clin Endocrinol Metab (2011) 0.77
Lower levels sex hormone-binding globulin independently associated with metabolic syndrome in pre-elderly and elderly men in China. J Geriatr Cardiol (2013) 0.77
Relevance of low testosterone to non-alcoholic fatty liver disease. Cardiovasc Endocrinol (2015) 0.77
The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population. Biomed Res Int (2013) 0.76
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet (2009) 7.24
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med (2004) 3.80
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol (2002) 3.66
Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am J Hum Genet (2007) 3.31
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med (2006) 3.05
Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes (2005) 2.82
MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome. Nat Genet (2006) 2.75
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol (2007) 2.74
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care (2002) 2.69
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation (2003) 2.63
Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol (2002) 2.57
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
Cardiorespiratory fitness and the risk for stroke in men. Arch Intern Med (2003) 2.22
Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol (2004) 2.15
The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study. Eur Heart J (2004) 1.96
Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology (2007) 1.92
Socioeconomic position across the lifecourse and cognitive function in late middle age. J Gerontol B Psychol Sci Soc Sci (2002) 1.92
National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health (2007) 1.92
Identification of CC2D2A as a Meckel syndrome gene adds an important piece to the ciliopathy puzzle. Am J Hum Genet (2008) 1.90
Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension (2004) 1.83
Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr (2008) 1.81
Occupational physical activity, energy expenditure and 11-year progression of carotid atherosclerosis. Scand J Work Environ Health (2007) 1.77
Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ Health Perspect (2008) 1.71
Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc (2003) 1.70
Systolic blood pressure during recovery from exercise and the risk of acute myocardial infarction in middle-aged men. Hypertension (2004) 1.67
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation (2004) 1.65
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr (2007) 1.65
Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med (2005) 1.62
Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study. Diabetes Care (2013) 1.59
The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr (2002) 1.57
Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart (2012) 1.54
Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.53
A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab (2005) 1.51
Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr (2004) 1.51
Incidence of cancer and statin usage--record linkage study. Int J Cancer (2010) 1.51
Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol (2003) 1.51
FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther (2005) 1.51
Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens (2004) 1.49
Perceived health as a predictor of early retirement. Scand J Work Environ Health (2004) 1.48
Serum long-chain n-3 polyunsaturated fatty acids, methylmercury and blood pressure in an older population. Hypertens Res (2012) 1.48
Effect of intensive counselling on physical activity in pregnant women at high risk for gestational diabetes mellitus. A clinical study in primary care. Prim Care Diabetes (2012) 1.46
[Insulin pump in the treatment of adult age diabetes]. Duodecim (2005) 1.46
Prenatally detected trisomy 7 mosaicism in a dysmorphic child. Prenat Diagn (2002) 1.44
Metabolic syndrome and the risk of prostate cancer in Finnish men: a population-based study. Cancer Epidemiol Biomarkers Prev (2004) 1.39
Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med (2005) 1.37
Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med (2004) 1.36
Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry (2003) 1.35
Birth weight and systolic blood pressure in adolescence and adulthood: meta-regression analysis of sex- and age-specific results from 20 Nordic studies. Am J Epidemiol (2007) 1.28
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am Coll Cardiol (2008) 1.26
Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation (2009) 1.25
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care (2007) 1.24
Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom (2004) 1.24